High quality genomic copy number data from archival formalin-fixed paraffin-embedded leiomyosarcoma: optimisation of universal linkage system labelling

PLoS One. 2012;7(11):e50415. doi: 10.1371/journal.pone.0050415. Epub 2012 Nov 29.

Abstract

Most soft tissue sarcomas are characterized by genetic instability and frequent genomic copy number aberrations that are not subtype-specific. Oligonucleotide microarray-based Comparative Genomic Hybridisation (array CGH) is an important technique used to map genome-wide copy number aberrations, but the traditional requirement for high-quality DNA typically obtained from fresh tissue has limited its use in sarcomas. Although large archives of Formalin-fixed Paraffin-embedded (FFPE) tumour samples are available for research, the degradative effects of formalin on DNA from these tissues has made labelling and analysis by array CGH technically challenging. The Universal Linkage System (ULS) may be used for a one-step chemical labelling of such degraded DNA. We have optimised the ULS labelling protocol to perform aCGH on archived FFPE leiomyosarcoma tissues using the 180k Agilent platform. Preservation age of samples ranged from a few months to seventeen years and the DNA showed a wide range of degradation (when visualised on agarose gels). Consistently high DNA labelling efficiency and low microarray probe-to-probe variation (as measured by the derivative log ratio spread) was seen. Comparison of paired fresh and FFPE samples from identical tumours showed good correlation of CNAs detected. Furthermore, the ability to macro-dissect FFPE samples permitted the detection of CNAs that were masked in fresh tissue. Aberrations were visually confirmed using Fluorescence in situ Hybridisation. These results suggest that archival FFPE tissue, with its relative abundance and attendant clinical data may be used for effective mapping for genomic copy number aberrations in such rare tumours as leiomyosarcoma and potentially unravel clues to tumour origins, progression and ultimately, targeted treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Chromosome Aberrations
  • Chromosome Mapping / methods
  • Comparative Genomic Hybridization / economics
  • Comparative Genomic Hybridization / instrumentation*
  • Comparative Genomic Hybridization / methods*
  • DNA / analysis
  • DNA / genetics
  • Electrophoresis, Agar Gel
  • Female
  • Gene Dosage*
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Genetic Techniques
  • Humans
  • In Situ Hybridization, Fluorescence
  • Leiomyosarcoma / metabolism*
  • Models, Genetic
  • Paraffin / chemistry*
  • Reproducibility of Results
  • Retrospective Studies
  • Specimen Handling

Substances

  • Paraffin
  • DNA

Grants and funding

This work was supported by funds from Sarcoma Trust/Sarcoma UK and also The Betty Waind Trust, Weston Park Hospital Cancer charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.